HEADER VIRAL PROTEIN 01-JAN-22 7WI0 TITLE SARS-COV-2 OMICRON VARIANT SPIKE IN COMPLEX WITH THREE HUMAN TITLE 2 NEUTRALIZING ANTIBODIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: XMA04 HEAVY CHAIN VARIABLE DOMAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: XMA01 HEAVY CHAIN VARIABLE DOMAIN; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: IGL C4029_LIGHT_IGKV1-39_IGKJ2; COMPND 15 CHAIN: D; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: IG C934_LIGHT_IGKV1-5_IGKJ1; COMPND 19 CHAIN: E; COMPND 20 ENGINEERED: YES; COMPND 21 MOL_ID: 6; COMPND 22 MOLECULE: XMA09 HEAVY CHAIN VARIABLE DOMAIN; COMPND 23 CHAIN: H; COMPND 24 ENGINEERED: YES; COMPND 25 MOL_ID: 7; COMPND 26 MOLECULE: IG C1437_LIGHT_IGLV1-40_IGLJ1; COMPND 27 CHAIN: L; COMPND 28 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: S, 2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 18 MOL_ID: 4; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 24 MOL_ID: 5; SOURCE 25 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 26 ORGANISM_COMMON: HUMAN; SOURCE 27 ORGANISM_TAXID: 9606; SOURCE 28 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 30 MOL_ID: 6; SOURCE 31 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 32 ORGANISM_TAXID: 9606; SOURCE 33 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 34 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 35 MOL_ID: 7; SOURCE 36 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 37 ORGANISM_COMMON: HUMAN; SOURCE 38 ORGANISM_TAXID: 9606; SOURCE 39 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 40 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, OMICRON, SPIKE PROTEIN, NEUTRALIZING ANTIBODY, CRYO-EM, KEYWDS 2 VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Q.ZHENG,S.LI,H.SUN,Z.ZHENG,S.WANG REVDAT 1 22-JUN-22 7WI0 0 JRNL AUTH S.WANG,H.SUN,Y.ZHANG,L.YUAN,Y.WANG,T.ZHANG,S.WANG,J.ZHANG, JRNL AUTH 2 H.YU,H.XIONG,Z.TANG,L.LIU,Y.HUANG,X.CHEN,T.LI,D.YING,C.LIU, JRNL AUTH 3 Z.CHEN,Q.YUAN,J.ZHANG,T.CHENG,S.LI,Y.GUAN,Q.ZHENG,Z.ZHENG, JRNL AUTH 4 N.XIA JRNL TITL THREE SARS-COV-2 ANTIBODIES PROVIDE BROAD AND SYNERGISTIC JRNL TITL 2 NEUTRALIZATION AGAINST VARIANTS OF CONCERN, INCLUDING JRNL TITL 3 OMICRON. JRNL REF CELL REP V. 39 10862 2022 JRNL REFN ESSN 2211-1247 JRNL PMID 35594869 JRNL DOI 10.1016/J.CELREP.2022.110862 REMARK 2 REMARK 2 RESOLUTION. 3.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.820 REMARK 3 NUMBER OF PARTICLES : 123163 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7WI0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1300026674. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 OMICRON VARIANT REMARK 245 SPIKE IN COMPLEX WITH THREE REMARK 245 HUMAN NEUTRALIZING ANTIBODIES REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TECNAI F30 REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEPTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 333 REMARK 465 GLU B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 THR C 78 C THR C 78 O 0.233 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY B 105 N - CA - C ANGL. DEV. = 17.8 DEGREES REMARK 500 LEU C 105 CA - CB - CG ANGL. DEV. = 16.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 418 -52.34 -123.54 REMARK 500 ASN A 422 -50.79 -122.54 REMARK 500 ASP A 428 35.94 -98.61 REMARK 500 ASP A 442 53.13 -94.90 REMARK 500 TYR A 449 6.56 -65.38 REMARK 500 ASN A 481 65.13 60.04 REMARK 500 THR B 31 48.42 -84.79 REMARK 500 VAL B 48 -60.47 -123.50 REMARK 500 ASP B 90 54.30 -96.12 REMARK 500 ALA B 92 -169.06 -162.75 REMARK 500 ARG B 98 145.34 -178.90 REMARK 500 SER C 25 -71.51 -81.81 REMARK 500 PHE C 27 -173.24 -172.21 REMARK 500 HIS C 35 -167.30 -126.10 REMARK 500 VAL C 48 -50.54 -122.44 REMARK 500 GLN C 103 -23.27 -148.61 REMARK 500 SER C 121 -168.98 -162.87 REMARK 500 ALA D 51 -7.50 67.62 REMARK 500 TYR D 92 -40.39 -132.57 REMARK 500 THR E 31 43.00 39.69 REMARK 500 THR E 51 -4.11 62.11 REMARK 500 PHE E 83 50.39 -92.41 REMARK 500 PHE E 91 32.61 -141.48 REMARK 500 ASP H 99 43.08 -104.63 REMARK 500 PRO H 112 -159.22 -82.91 REMARK 500 ASN L 53 -10.82 70.48 REMARK 500 SER L 54 -18.07 -142.71 REMARK 500 SER L 96 38.34 -97.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-32517 RELATED DB: EMDB REMARK 900 SARS-COV-2 OMICRON VARIANT SPIKE IN COMPLEX WITH THREE HUMAN REMARK 900 NEUTRALIZING ANTIBODIES DBREF 7WI0 A 333 527 UNP P0DTC2 SPIKE_SARS2 333 527 DBREF 7WI0 B 1 124 PDB 7WI0 7WI0 1 124 DBREF 7WI0 C 1 122 PDB 7WI0 7WI0 1 122 DBREF1 7WI0 D 1 107 UNP A0A5C2G4I7_HUMAN DBREF2 7WI0 D A0A5C2G4I7 1 107 DBREF1 7WI0 E 1 107 UNP A0A5C2GTV1_HUMAN DBREF2 7WI0 E A0A5C2GTV1 1 107 DBREF 7WI0 H 1 123 PDB 7WI0 7WI0 1 123 DBREF1 7WI0 L 1 110 UNP A0A5C2GVU3_HUMAN DBREF2 7WI0 L A0A5C2GVU3 1 111 SEQADV 7WI0 ASP A 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 7WI0 LEU A 371 UNP P0DTC2 SER 371 VARIANT SEQADV 7WI0 PRO A 373 UNP P0DTC2 SER 373 VARIANT SEQADV 7WI0 PHE A 375 UNP P0DTC2 SER 375 VARIANT SEQADV 7WI0 ASN A 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 7WI0 LYS A 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 7WI0 SER A 446 UNP P0DTC2 GLY 446 VARIANT SEQADV 7WI0 ASN A 477 UNP P0DTC2 SER 477 VARIANT SEQADV 7WI0 LYS A 478 UNP P0DTC2 THR 478 VARIANT SEQADV 7WI0 ALA A 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 7WI0 ARG A 493 UNP P0DTC2 GLN 493 VARIANT SEQADV 7WI0 SER A 496 UNP P0DTC2 GLY 496 VARIANT SEQADV 7WI0 ARG A 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 7WI0 TYR A 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 7WI0 HIS A 505 UNP P0DTC2 TYR 505 VARIANT SEQADV 7WI0 ASN D 31 UNP A0A5C2G4I SER 31 CONFLICT SEQADV 7WI0 PHE D 32 UNP A0A5C2G4I TYR 32 CONFLICT SEQADV 7WI0 SER D 97 UNP A0A5C2G4I THR 97 CONFLICT SEQADV 7WI0 VAL E 9 UNP A0A5C2GTV SER 9 CONFLICT SEQADV 7WI0 SER E 10 UNP A0A5C2GTV THR 10 CONFLICT SEQADV 7WI0 THR E 31 UNP A0A5C2GTV SER 31 CONFLICT SEQADV 7WI0 GLU E 50 UNP A0A5C2GTV LYS 50 CONFLICT SEQADV 7WI0 PHE E 91 UNP A0A5C2GTV TYR 91 CONFLICT SEQADV 7WI0 TYR E 94 UNP A0A5C2GTV SER 94 CONFLICT SEQADV 7WI0 SER L 31 UNP A0A5C2GVU ALA 31 CONFLICT SEQADV 7WI0 LEU L 48 UNP A0A5C2GVU ARG 48 CONFLICT SEQADV 7WI0 L UNP A0A5C2GVU TYR 100 DELETION SEQRES 1 A 195 THR ASN LEU CYS PRO PHE ASP GLU VAL PHE ASN ALA THR SEQRES 2 A 195 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 A 195 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN LEU SEQRES 4 A 195 ALA PRO PHE PHE THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 A 195 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 A 195 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 A 195 ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN TYR SEQRES 8 A 195 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 A 195 ASN SER ASN LYS LEU ASP SER LYS VAL SER GLY ASN TYR SEQRES 10 A 195 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 A 195 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 A 195 GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY PHE ASN CYS SEQRES 13 A 195 TYR PHE PRO LEU ARG SER TYR SER PHE ARG PRO THR TYR SEQRES 14 A 195 GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 A 195 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 1 B 124 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 B 124 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 124 PHE THR PHE ARG THR TYR ALA MET HIS TRP VAL ARG GLN SEQRES 4 B 124 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA VAL MET TRP SEQRES 5 B 124 ASN ASP GLY SER ASN LYS TYR TYR ALA ASP SER VAL LYS SEQRES 6 B 124 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 B 124 LEU TYR LEU GLU MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 B 124 ALA VAL TYR TYR CYS ALA ARG GLU GLY VAL ALA ALA ALA SEQRES 9 B 124 GLY SER SER SER ASP ALA PHE ASP ILE TRP GLY GLN GLY SEQRES 10 B 124 THR MET VAL THR VAL SER SER SEQRES 1 C 122 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 C 122 PRO GLY GLY SER LEU ARG LEU SER CYS SER ALA SER GLY SEQRES 3 C 122 PHE THR PHE SER SER TYR ALA MET HIS TRP VAL ARG GLN SEQRES 4 C 122 ALA PRO GLY LYS GLY LEU GLU TYR VAL SER SER ILE SER SEQRES 5 C 122 SER ASN GLY GLY SER THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 C 122 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 C 122 LEU TYR LEU GLN MET SER SER LEU ARG VAL GLU ASP ALA SEQRES 8 C 122 ALA VAL TYR TYR CYS VAL LYS HIS TYR GLN GLN GLN LEU SEQRES 9 C 122 LEU TRP GLY GLY PRO ASP VAL TRP GLY GLN GLY THR THR SEQRES 10 C 122 VAL THR VAL SER SER SEQRES 1 D 107 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 D 107 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 D 107 GLN SER ILE SER ASN PHE LEU ASN TRP TYR GLN GLN LYS SEQRES 4 D 107 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ALA ALA SER SEQRES 5 D 107 SER LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 D 107 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 D 107 GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN SER SEQRES 8 D 107 TYR SER THR LEU TYR SER PHE GLY GLN GLY THR LYS LEU SEQRES 9 D 107 GLU ILE LYS SEQRES 1 E 107 ASP ILE GLN MET THR GLN SER PRO VAL SER LEU SER ALA SEQRES 2 E 107 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 E 107 GLN SER ILE SER THR TRP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 E 107 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR GLU THR SER SEQRES 5 E 107 SER LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 E 107 GLY SER GLY THR GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 E 107 GLN PRO ASP ASP PHE ALA THR TYR TYR CYS GLN GLN PHE SEQRES 8 E 107 ASN SER TYR PRO TRP THR PHE GLY GLN GLY THR LYS VAL SEQRES 9 E 107 GLU ILE LYS SEQRES 1 H 123 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 H 123 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 H 123 GLY THR PHE SER SER PHE ALA ILE SER TRP VAL ARG GLN SEQRES 4 H 123 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY GLY ILE ILE SEQRES 5 H 123 PRO ILE TYR GLY THR ALA ASN TYR ALA GLN LYS PHE GLN SEQRES 6 H 123 GLY ARG VAL THR ILE THR ALA ASP GLU SER THR SER THR SEQRES 7 H 123 ALA TYR MET ASP LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 H 123 ALA VAL TYR TYR CYS ALA ARG ASP GLY SER SER THR TYR SEQRES 9 H 123 TYR PRO HIS ASN TRP PHE ASP PRO TRP GLY GLN GLY THR SEQRES 10 H 123 LEU VAL THR VAL SER SER SEQRES 1 L 110 GLN SER VAL LEU THR GLN PRO PRO SER VAL SER GLY ALA SEQRES 2 L 110 PRO GLY GLN ARG VAL THR ILE SER CYS THR GLY SER SER SEQRES 3 L 110 SER ASN ILE GLY SER GLY TYR ASP VAL HIS TRP TYR GLN SEQRES 4 L 110 GLN LEU PRO GLY THR ALA PRO LYS LEU LEU ILE TYR GLY SEQRES 5 L 110 ASN SER ASN ARG PRO SER GLY VAL PRO ASP ARG PHE SER SEQRES 6 L 110 GLY SER LYS SER GLY THR SER ALA SER LEU ALA ILE THR SEQRES 7 L 110 GLY LEU GLN ALA GLU ASP GLU ALA ASP TYR TYR CYS GLN SEQRES 8 L 110 SER TYR ASP SER SER LEU SER GLY VAL PHE GLY THR GLY SEQRES 9 L 110 THR LYS VAL THR VAL LEU HET NAG A 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 8 NAG C8 H15 N O6 HELIX 1 AA1 PRO A 337 VAL A 341 5 5 HELIX 2 AA2 ASP A 364 LEU A 368 5 5 HELIX 3 AA3 LYS A 386 ASP A 389 5 4 HELIX 4 AA4 GLU A 406 ILE A 410 5 5 HELIX 5 AA5 ARG C 87 ALA C 91 5 5 SHEET 1 AA1 5 ASN A 354 ILE A 358 0 SHEET 2 AA1 5 ASN A 394 ARG A 403 -1 O VAL A 395 N ILE A 358 SHEET 3 AA1 5 PRO A 507 GLU A 516 -1 O SER A 514 N TYR A 396 SHEET 4 AA1 5 GLY A 431 ALA A 435 -1 N ILE A 434 O VAL A 511 SHEET 5 AA1 5 THR A 376 TYR A 380 -1 N LYS A 378 O VAL A 433 SHEET 1 AA2 3 CYS A 361 VAL A 362 0 SHEET 2 AA2 3 VAL A 524 CYS A 525 1 O CYS A 525 N CYS A 361 SHEET 3 AA2 3 CYS A 391 PHE A 392 -1 N PHE A 392 O VAL A 524 SHEET 1 AA3 2 TYR A 453 ARG A 454 0 SHEET 2 AA3 2 LEU A 492 ARG A 493 -1 O ARG A 493 N TYR A 453 SHEET 1 AA4 2 TYR A 473 GLN A 474 0 SHEET 2 AA4 2 CYS A 488 TYR A 489 -1 O TYR A 489 N TYR A 473 SHEET 1 AA5 2 LEU B 4 GLU B 6 0 SHEET 2 AA5 2 CYS B 22 ALA B 24 -1 O ALA B 23 N VAL B 5 SHEET 1 AA6 5 VAL B 11 VAL B 12 0 SHEET 2 AA6 5 THR B 118 VAL B 122 1 O THR B 121 N VAL B 12 SHEET 3 AA6 5 ALA B 92 TYR B 94 -1 N TYR B 94 O THR B 118 SHEET 4 AA6 5 HIS B 35 GLN B 39 -1 N GLN B 39 O VAL B 93 SHEET 5 AA6 5 LEU B 45 VAL B 50 -1 O GLU B 46 N ARG B 38 SHEET 1 AA7 3 LEU B 18 LEU B 20 0 SHEET 2 AA7 3 THR B 78 MET B 83 -1 O LEU B 81 N LEU B 20 SHEET 3 AA7 3 PHE B 68 ASP B 73 -1 N THR B 69 O GLU B 82 SHEET 1 AA8 4 GLU C 6 SER C 7 0 SHEET 2 AA8 4 SER C 17 CYS C 22 -1 O SER C 21 N SER C 7 SHEET 3 AA8 4 THR C 78 SER C 84 -1 O LEU C 79 N CYS C 22 SHEET 4 AA8 4 THR C 69 ASP C 73 -1 N SER C 71 O TYR C 80 SHEET 1 AA9 6 GLY C 10 VAL C 12 0 SHEET 2 AA9 6 THR C 116 VAL C 120 1 O THR C 117 N GLY C 10 SHEET 3 AA9 6 VAL C 93 LYS C 98 -1 N TYR C 94 O THR C 116 SHEET 4 AA9 6 MET C 34 GLN C 39 -1 N HIS C 35 O VAL C 97 SHEET 5 AA9 6 LEU C 45 SER C 50 -1 O GLU C 46 N ARG C 38 SHEET 6 AA9 6 TYR C 59 TYR C 60 -1 O TYR C 59 N SER C 50 SHEET 1 AB1 4 MET D 4 SER D 7 0 SHEET 2 AB1 4 VAL D 19 ILE D 29 -1 O ARG D 24 N THR D 5 SHEET 3 AB1 4 GLY D 68 ILE D 75 -1 O LEU D 73 N ILE D 21 SHEET 4 AB1 4 PHE D 62 GLY D 66 -1 N SER D 63 O THR D 74 SHEET 1 AB2 2 SER D 10 SER D 12 0 SHEET 2 AB2 2 LYS D 103 GLU D 105 1 O LYS D 103 N LEU D 11 SHEET 1 AB3 4 SER D 53 LEU D 54 0 SHEET 2 AB3 4 LYS D 45 TYR D 49 -1 N TYR D 49 O SER D 53 SHEET 3 AB3 4 LEU D 33 GLN D 38 -1 N TRP D 35 O ILE D 48 SHEET 4 AB3 4 THR D 85 GLN D 90 -1 O GLN D 89 N ASN D 34 SHEET 1 AB4 4 THR E 5 SER E 7 0 SHEET 2 AB4 4 VAL E 19 ARG E 24 -1 O THR E 22 N SER E 7 SHEET 3 AB4 4 GLU E 70 ILE E 75 -1 O LEU E 73 N ILE E 21 SHEET 4 AB4 4 PHE E 62 GLY E 64 -1 N SER E 63 O THR E 74 SHEET 1 AB5 2 SER E 10 SER E 12 0 SHEET 2 AB5 2 LYS E 103 GLU E 105 1 O GLU E 105 N LEU E 11 SHEET 1 AB6 4 SER E 53 LEU E 54 0 SHEET 2 AB6 4 LYS E 45 TYR E 49 -1 N TYR E 49 O SER E 53 SHEET 3 AB6 4 LEU E 33 GLN E 38 -1 N TRP E 35 O LEU E 47 SHEET 4 AB6 4 THR E 85 GLN E 90 -1 O TYR E 87 N TYR E 36 SHEET 1 AB7 2 GLN H 3 GLN H 6 0 SHEET 2 AB7 2 CYS H 22 SER H 25 -1 O LYS H 23 N VAL H 5 SHEET 1 AB8 6 GLU H 10 LYS H 12 0 SHEET 2 AB8 6 LEU H 118 VAL H 121 1 O THR H 120 N GLU H 10 SHEET 3 AB8 6 ALA H 92 ALA H 97 -1 N ALA H 92 O VAL H 119 SHEET 4 AB8 6 SER H 35 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 5 AB8 6 TRP H 47 ILE H 51 -1 O MET H 48 N TRP H 36 SHEET 6 AB8 6 ALA H 58 TYR H 60 -1 O ASN H 59 N GLY H 50 SHEET 1 AB9 3 VAL H 18 LYS H 19 0 SHEET 2 AB9 3 ASP H 82 LEU H 83 -1 O LEU H 83 N VAL H 18 SHEET 3 AB9 3 VAL H 68 THR H 69 -1 N THR H 69 O ASP H 82 SHEET 1 AC1 2 ALA H 72 ASP H 73 0 SHEET 2 AC1 2 THR H 78 ALA H 79 -1 O THR H 78 N ASP H 73 SHEET 1 AC2 5 SER L 9 SER L 11 0 SHEET 2 AC2 5 THR L 105 THR L 108 1 O LYS L 106 N VAL L 10 SHEET 3 AC2 5 ALA L 86 TYR L 93 -1 N ALA L 86 O VAL L 107 SHEET 4 AC2 5 HIS L 36 GLN L 40 -1 N GLN L 40 O ASP L 87 SHEET 5 AC2 5 LYS L 47 ILE L 50 -1 O LYS L 47 N GLN L 39 SHEET 1 AC3 4 SER L 9 SER L 11 0 SHEET 2 AC3 4 THR L 105 THR L 108 1 O LYS L 106 N VAL L 10 SHEET 3 AC3 4 ALA L 86 TYR L 93 -1 N ALA L 86 O VAL L 107 SHEET 4 AC3 4 GLY L 99 PHE L 101 -1 O VAL L 100 N SER L 92 SHEET 1 AC4 3 ARG L 17 SER L 21 0 SHEET 2 AC4 3 SER L 72 THR L 78 -1 O ILE L 77 N VAL L 18 SHEET 3 AC4 3 PHE L 64 SER L 69 -1 N SER L 65 O ALA L 76 SSBOND 1 CYS A 480 CYS A 488 1555 1555 2.03 SSBOND 2 CYS B 22 CYS B 96 1555 1555 2.04 SSBOND 3 CYS C 22 CYS C 96 1555 1555 2.01 SSBOND 4 CYS D 23 CYS D 88 1555 1555 2.03 SSBOND 5 CYS E 23 CYS E 88 1555 1555 2.04 SSBOND 6 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 7 CYS L 22 CYS L 90 1555 1555 2.03 LINK ND2 ASN A 343 C1 NAG A 601 1555 1555 1.44 CISPEP 1 SER D 7 PRO D 8 0 -3.66 CISPEP 2 SER E 7 PRO E 8 0 -0.46 CISPEP 3 ASP H 111 PRO H 112 0 -4.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000